ISSN: 1935-1232 (P)

ISSN: 1941-2010 (E)


Review Article - Clinical Schizophrenia & Related Psychoses ( 2021) Volume 0, Issue 0

Raghad Riyadh Khali*, Eman Tareq Mohammed and Yasser Fakri Mustafa
Department of Pharmaceutical Chemistry, University of Mosul, Mosul, Iraq
*Corresponding Author:
Raghad Riyadh Khali, Department of Pharmaceutical Chemistry, University of Mosul, Mosul, Iraq, Email:

Received: 04-Aug-2021 Accepted Date: Aug 18, 2021 ; Published: 25-Aug-2021


Cranberry is a well-known natural occurring product that has been used for centuries in traditional medicine to promote urinary tract health. Besides that, Cranberry has shown promising biomedicine activity in the prevention and treatment of many human disorders. The presence of polyphenolic entities such as proanthocyanidins, anthocyanins, flavonols, and other chemo-constituents is commonly linked to the positive effects of this natural product on human health. Cranberry and its extract were developed and marketed as nutraceutical supplements, and their antioxidant, antibacterial, anti-inflammatory, and anticancer properties allow them to be used for managing a variety of ailments, including microbial infections, metabolic syndrome elements, and cancer. The focus of this paper is on some of the recent studies which explore the potential pharmacological activities of Cranberry extract. Ultimately, this study concluded that cranberry extract can offer a feasible and prospective phytochemical option for treating many disorders affecting human health.


Cranberry •Cranberry extract •Antimicrobial •Antioxidant •Anti-inflammatory


Nature, predominately through plants, has always been an inexhaustible source of bioactive compounds. In many different cultures, phytotherapy has had a well-known effect on the treatment and prevention of various diseases [1]. According to the World Health Organization (WHO), about eighty percent of the world's population, primarily in developing countries, relies on conventional plant-derived medicines for primary health care, while plant products continue to play a significant, albeit indirect role in the health care systems of the developed countries [2]. Better compatibility with the human body and relatively fewer side effects of botanical-based medicine, in comparison with synthetic compounds, may shift the global trend of synthetic drugs, in the past few decades, to herbal medicines, that intimates a return to nature to treat different ailments [3-5].

North American Cranberry (Vaccinium macrocarpon), which belongs to the Ericaceae family is a woody, low-growing, vining perennial plant native to northeastern North America, extending from eastern Canada to North Carolina in the United States. This edible red fruit is one of the economically significant North American fruits [6], while Vaccinium oxycoccus is the European variety, which is grown in portions of central Europe, Germany, and Finland. Vaccinium oxycoccus is a smaller fruit with slightly different acid profiles and anthocyanin than the North American variant [7]. Native Americans employed the Vaccinium macrocarpon as a food source and natural deterrent against bladder and kidney disorders. Furthermore, during ocean trips, American sailors used Cranberries as an antiscorbutic agent [6,8].

The promising health potential of V. macrocarpon, which received the most attention for its advantageous effects on human health dating back to the 17th century, led within the last few decades to the popularity of Cranberry's dietary supplements as an alternative and convenient dietary source of Cranberry phytochemicals. These supplements profess to be manufactured from concentrated Cranberry extracts, freeze-dried Cranberry powders, or Cranberry phenolic isolate products and advertised for their high equivalence values to the fresh fruit and a variety of putative health advantages, including urinary tract health support [9-12].

Chemo-constituents of cranberry and its cultivars

Cranberries are a varied and abundant source of phytochemicals. More than one hundred fifty phytochemicals have been discovered and studied in Cranberry and its cultivars so far. However, more ingredients can be discovered as analytical techniques developed [13].

Flavonoids seem to be the most predominant chemo-constituent phenotype. Also, other chemo-constituents have been recognized, such as Anthocyanins, which give Cranberries their bright red color; proanthocyanidins, which protect against urinary tract infections; flavonols, the secondary yellowish pigments; terpene; and pectins; While the sour and astringent flavor of Cranberries is due to catechins, organic acids, and resveratrol [13].


Anthocyanins are arguably the most investigated phytoconstituent and are responsible for the fruit's characteristic red color. Anthocyanins are found mainly in the colored bodies of the exocarp layer of the fruit's pericarp, and they increase as the fruit matures [14-16]. Whole, raw Cranberry fruits contain substantial albeit inconsistent quantities of anthocyanins, ranging from 13.6 to 140 mg/100 g depending primarily on the cultivar, place of growth, fruit size, climatic, genetic, environmental, and other factors [13,16].

Chemically, anthocyanins consisting of an anthocyanidin backbone attached to a single or multiple sugar moieties. V. macrocarpon is one of the rare foods that muster glycosides of six aglycones of the anthocyanidin family: petunidin, cyanidin, delphinidin, pelargonidin, peonidin, and malvidin (Figure 1). The prevalent anthocyanins are 3-O-arabinosides and 3-O-galactosides of peonidin and cyanidin; a total of thirteen anthocyanins, mainly 3-O-monoglycosides, have been discovered [7,17,18].


Figure 1. The general chemical structure of the Cranberry’s anthocyanidins (18).

Viskelis et al. Investigated four American Cranberry cultivars and reported that the average composition of the anthocyanins in these cultivars was as the following: peonidin-3-galactoside (32.7% ± 1.2%), cyanidin-3- galactoside (20.5% ± 1.8%), cyanidin-3-arabinoside (19% ± 3.3%), peonidin-3-arabinoside (6.7% ± 1.2%) peonidin-3-glucoside (3.5% ± 1.3%), and cyanidin-3-glucoside (2.3% ± 0.3%) [19]. However, recent analyzes have revealed a difference in the anthocyanin content of different processed Cranberry products and supplements [2022].


Flavonols are found in a multitude of Cranberry fruits, mostly in glycosylated forms of myricetin, quercetin, and to a lesser extent, kaempferol. Quercetin glycosides (mainly quercetin 3-O-galactoside) (Figure 2) forming about 75% of the Cranberry flavonols. A wide range of flavonols was detected, many of which are found in low concentrations, such as quercetin, myricetin, myricetin 3-O-arabinofuranoside, myricetin 3-O-galactoside, myricetin 3-O-xylopyranoside, myricetin 3-O-arabinopyranoside, and myricetin 3-O-rhamnoside [14,2327].

Flavan-3-ols are significant metabolites of Cranberry. They possess the flavonoid scaffold as flavonols but without the C4 carbonyl group. They arise naturally in the plant as aglycons of epicatechin and catechin. Unlike other flavonoids, their good solubility allows them to stay in the vacuole with no need for glycosylation [7,13]. Flavonols and flavan-3-ols have received a lot of researchers' interest due to their supposed beneficial health properties [23].


Figure 2. The chemical backbone of quercetin-3-galactoside (28).

Flavan-3-ols are significant metabolites of Cranberry. They possess the flavonoid scaffold as flavonols but without the C4 carbonyl group. They arise naturally in the plant as aglycons of epicatechin and catechin. Unlike other flavonoids, their good solubility allows them to stay in the vacuole with no need for glycosylation [7,13]. Flavonols and flavan-3-ols have received a lot of researchers' interest due to their supposed beneficial health properties [23].


One of the exceptional properties of Cranberries is their diverse group of proanthocyanidins (PACs) content, also referred to as non-hydrolysable condensed tannins,that exhibit several unique structural characteristics. The flavan-3-ols mostly epicatechin and catechin are the monomeric units used by the plant to assemble oligomeric or polymeric structures known as PACs.

Although the mechanism by which this condensation occurs in the plant is not fully understood, two types of this chemical process have been identified. In the less commonly type named B, the condensation occurs via an inter-flavan bond between the flavan-3-ol units, where these monomeric units coupled primarily by bonds between C-4 and C-8, though connections between C-4 and C-6. On the other hand, type-A proanthocyanidins are characterized by an additional bond between C-2 and C-7 of the underlying flavan-3-ol units (Figure 3) [29-31].


Figure 3. Chemical backbones of the PAC trimers and dimers isolated from Cranberries. (A) epicatechin- (4-6)-epicatechin-(4-8,2-O-7)- epicatechin, (B) epicatechin-(4-8,2-O-7)-epicatechin- (4-8)-epicatechin, (C) epicatechin-(4-8)- epicatechin-(4-8,2-O-7)-epicatechin,(D) epicatechin-(4- 8,2-O-7)-epicatechin, (E) epicatechin- (4-8)-epicatechin (13).

The degree of PAC polymerization (DP) is determined by the source and processing of the fruit. PACs with DP equal to 23 and 26 have been detected in Cranberries using mass spectroscopy. These structural characteristics of PACs are responsible for their various and interesting bioactivities [29,32,33].

According to Gardana et al., the PAC content of different Cranberry cultivars ranging from 1471 mg/100 g-6563 mg/100 g of dry weight [34], while commercial extracts are standardized to 15% and 33% PAC. Because of this high content, Cranberry is considered as an expensive natural extract. Unfortunately, this has resulted in the adulteration of Cranberrybased products when inexpensive sources of PACs are employed and not disclosed on the label [13,34,35].

Other chemo-constituents

In the American version of the cranberry fruit, derivatives of the ursane type of triterpenoids, such as betulinic acid, oleanolic acid, and ursolic acid, were identified. In a study of six American Cranberry cultivars, Oszmia´nski et al. discovered that ursolic acid, the pentacyclic triterpene, was the most abundant triterpenoid (ranging from 50%-37%), followed by oleanolic acid (ranging from 28%-35%), and betulinic acid (ranged from 19%-28%) [36].

In addition, Cranberry contains phenolic acids, including hydroxycinnamic and hydroxybenzoic acid derivatives. The former is the most abundant. The foremost phenolic acids in Cranberry are caffeic acid, chlorogenic acid, ferulic acid, gallic acid, p-coumaric acid, protocatechuic acid, 3-hydroxybenzoic acid, 3-hydroxyphenylpropionic acid, 4-hydroxybenzoic acid, and 4-hydroxyphenylacetic [37].

Cranberry supplements may show ingredients profile that is somewhat different from that found in the other Cranberry products. Ursolic acid and oleanolic acid are found primarily in the fruit peel, which may not be used in supplements manufacturing. In most cases, there is no clear information on the label about the sources and forms used, whether whole fruit, juice, or extract. The reduced PAC content in most supplements could be due to the peel removal during the manufacturing process. The fruits are often squeezed or pressed during the Cranberries processing, and the residual pomace is dumped as a waste product. Furthermore, any fruit processing that requires extended exposure to light and heat has the potential to destroy the existing anthocyanin molecules [22,38].

Biomedical Activities

Anti-pathogenic potentials

Antiviral effect: With the rise in antiviral resistance and the emergence of new viral pathogens, there is an urgent need for antiviral medications that are commonly available, inexpensive and have few adverse effects. Many traditional medicines, which contain various plant metabolites, exhibited significant antiviral properties are now validated as new antivirals. Recently, studies have increasingly harangued the suitability of Cranberry extracts as promising antiviral agents [39,40].

Non-Dialyzable Materials (NDM) of high molecular weight isolated from Cranberry juice were reported to reduce influenza virus adhesion and infectivity; probably by preventing viral adsorption onto the cells [41]. Where Weiss et al. discovered that low NDM concentrations, which are twentyfold lower than those found in Cranberry juice, inhibits hemagglutination of RBCs induced by both influenza virus B and the A subtypes (H3N2 and H1N1). Pre-incubation of Madine-Darby Canine Kidney (MDCK) cells with NDM (250 g/ml) considerably reduced the infectivity of the influenza A and B subtypes, as evidenced by the lack of cytopathic effect on MDCK cells and hemagglutination activity in the medium of infected cells. Suggesting it hinders viral offspring generated by infected cells from adsorbing onto new cells [42].

Because Hemagglutinin (HA) and Neuraminidase (NA), the influenza virus surface glycoproteins, are crucial for the replication and infection of the virus, Oiknine-Djian et al. Examined the NDM's effect on neuraminidases, as these are the target of most marketed anti-influenza medications. They found that the enzymatic activity of NA of both influenza virus A and B strains in addition to that of Streptococcus pneumoniae can be inhibited by NDM. The NDM's anti-NA activity was found to be promising against different influenza virus strains and moderately active against Streptococcus pneumoniae NA. This finding is significant in light of the increasing prevalence of influenza isolates resistant to antiviral medicines, which has reached 90% in some areas. In addition to the therapeutic potential against both A and B influenza virus infections, this study suggested that cranberry constituents might also stymie the development of subsequent secondary bacterial complications [43].

In this context, V. macrocarpon extracts may give prospective chemicals capable of preventing viral attachment to the target cells basing on their known anti-adhesive actions against bacteria [44].

Oximacro, traditionally available Cranberry extract containing a high concentration of PACs type-A, has been shown to have a significant dosedependent antiviral effect against influenza A and B viruses, according to Luganini et al. Mechanistic experiments have demonstrated that the extract may inhibit the binding and penetration of influenza virus into target cells plus its virucidal properties. It was discovered that the extract may interact with the ectodomain of the viral hemagglutinin glycoprotein, implying interference with hemagglutinin activities and, as a result, loss of influenza virus particle infectivity. Fluorescence spectroscopy and in silico docking simulations confirmed the in-vitro findings, indicating that PAC-A2 (Dimeric catechin) is the predominant anti-influenza virus component among the several ingredients of this extract. The involvement of PAC-A2 in anti-influenza virus action was further verified when it was shown that it suppressed influenza virus reproduction. Overall, these findings point to Cranberry extracts as a promising candidate for developing innovative natural antiviral medicines to prevent influenza virus infections [45].

Hydrogen bonding, electrostatic interactions, van der Waals, as well as covalent bond formation, are expected to play a major role in the development of protein-PAC complexes. In this context, Terlizzi et al. found that the PACs type-A of Oximacro extract may protect against Herpes Simplex Type 1 (HSV-1) and Herpes Simplex Type 2 (HSV-2) infection through a similar biochemical process. This route involving changes in the envelope glycoproteins essential for entrance, such as gB and gD. The antiadhesive activity of this extract on HSV is attributable to direct contacts with the virion surface, as evidenced by interaction studies between PACs and either HSV particles or the ectodomain of pure gD protein.

Moreover, Cranberry extract may inhibit the in vitro replication of these DNA viruses. Even at acidic pH values (3.0- 4.0) and in the presence of 10% human serum proteins, this extract was maintained its anti-HSV activity, simulating the physiological features of the vagina as a prospective therapeutic location [46].

Overall, these findings point to Cranberry extract as a promising candidate for developing innovative natural antiviral medicines to prevent and treat RNA and DNA viruses' infections. The antiviral activity of Cranberry extract against human norovirus surrogates, Feline Calicivirus (FCV-F9), Murine Norovirus (MNV-1), and bacteriophage MS2 has been also investigated [47-49].

Based on the aforementioned studies, the proposed mechanism of the Cranberry extract could be associated with the direct binding between procyanidins and viral capsid proteins. This interaction can afford viral particle aggregation, which cause significant structural and morphological changes in the viral capsid and/or blocking of antigenic binding sites, resulting in reduced overall viral infectivity [50-52]. The integrity of the rotavirus capsid appears to be compromised by Cranberry's PACs. Direct viral testing indicates not only the absence of viral antigen but also a PAC-related inhibition or alteration of the rotavirus antigenic attachment determinants. These events appear to significantly lower the rotavirus infectivity [52-54].

Based on the findings of the studies involved in this review, Cranberry extract appears to have the potential as a natural antiviral remedy for treating and preventing foodborne and other virus infections. Also, the Covid-19 crisis highlighted the urgent need for improving the currently-available therapeutic facilities and exploring the antiviral potentials of various natural occurring products [40,55].

Antibacterial effect: Cranberry extract has been shown to have an antimicrobial activity against various pathogenic bacteria, including Staphylococcus aureus, E. coli, Helicobacter pylori, Campylobacter, and Salmonella. This would explain the apparent significance of the extract to prevent certain infectious diseases, such as Urinary Tract Infections (UTIs), stomach ulcers, and tooth decay [19].

UTI is one of the most prevalent bacterial illnesses in humans, with Escherichia coli being the most common cause. UTI affects up to 40%–50% of women at some point during their lives. The high frequency of UTIs, as well as the alarming growth in the antibiotic resistance among uropathogens, highlight the need for novel approaches to treat and prevent UTIs [56,57].

For too many years, Cranberry juice is being used as a remedy to treat and avert UTIs. Spanned to the present of some evidence that Cranberry juice can reduce the number of symptomatic urinary tract infections over one year, especially in women who have recurrent UTIs. These findings led the French Food Safety Authority to make the first-ever health claim on berry phenolics in 2004: A daily intake of 36 mg of Cranberry proanthocyanidins helps reduce the adherence of certain E. coli bacteria to the epithelium of the urinary tract [19,56].

Thereby, many studies have demonstrated the effectiveness of PACstandardized Cranberry supplements against bacterial adhesion and virulence in the urinary tract. Thus, these supplements can offer a means to cure and prevent UTIs [56,58]. Oral supplementation of a 120 mg capsule of Cranberry extract, standardized to 36 mg proanthocyanidins, for sixty days provided a prophylaxis in young, healthy subjects suffering from recurrent UTIs [59]. Furthermore, oral Cranberry supplementation reported to be effective in preventing UTI recurrence in healthy women [60].

Postmenopausal women, pregnant as well as lactating women, elderly men with benign prostatic hyperplasia, and children [61-64].

It is believed that the PACs, particularly type A phenotype, may act on the initial step of infection by inhibiting E. coli from the adherence to uroepithelial cells in a dose-dependent manner. PAC can bind to the E. coli and render bacteria non-adherent, probably by binding to fimbrial tips and compressing them, reducing adhesive forces and consequently influencing the first stage of infection. Also, PAC can decrease the number of fimbriae in E. coli in addition to compressing them. Because these mechanisms do not kill bacteria, there is a lower chance of resistant bacterial strains being selected. PAC derived from Cranberries may inhibit the multi-drug resistant E. coli strains from adhering to uroepithelial cells by 70% [29,58].

Another mechanism postulated is that quinic acid enhances the excretion of hippuric acid in the urine, which has an antibacterial effect, thus prevents the bacterial infection. Another explanation is that fructose inhibits fimbriated E. Coli from adhering to uroepithelial cells. While another theory proposed that Cranberry can affect the concentration of Tamm-Horsfall glycoproteins in urine, preventing E. coli from adherence to the human kidney [65,66].

Helicobacter pylori is a spiral-shaped Gram-negative bacteria that infect over half of the world's population. Chronic gastritis, peptic ulcer disease, mucosa-associated lymphoid tissue lymphoma, and gastric cancer are all thought to be caused by H. pylori infection in the stomach. It's difficult enough to choose the optimal treatment regimens for eradicating H. pylori infection. The most common causes of treatment failure are antibiotic resistance caused by frequent and unregulated usage, as well as a high prevalence of antibiotic side effects. To increase the rate of H. Pylori eradication, a variety of approaches are developed, such as prolonging the treatment period, utilizing new antibiotics, or including natural anti-H. Pylori food products like Cranberry in the treatment [67,68].

The anti-H. pylori characteristics of Cranberry may be accomplished through multiple modes of action, such as bacterial growth inhibition, enzyme inhibition such as urease as well as proline dehydrogenase, anti-adhesion activity, morphological changes, and inhibition of inflammatory cytokines secretion including IL-8 from gastric cells induced by H. pylori [68,69].

According to a study conducted in Gorgan, Iran, the addition of Cranberry to the proton pump inhibitor-based triple therapy for H. pylori had a significant and greater rate of eradication than the usual regimen alone. H. pylori positive patients with peptic ulcer disease were randomly assigned to one of two groups: the first one received a two weeks triple therapy consisting of 30 mg lansoprazole bid, 0.5 g clarithromycin bid, and 1 g amoxicillin bid, while the second group received two weeks 0.5 g Cranberry capsules bid along with the same triple therapy. Bacterial eradication has been assessed using a 13C-urea breath test six weeks after the completion of the treatment. In the first group, H. pylori eradication was achieved in 74% while the percent was 89% in the second group [67].

Dental caries is a multifactorial ailment induced by acid-producing bacteria that are entrenched in the biofilm of dental plaque and ferment dietary carbohydrates like sucrose [70]. Enamel demineralization occurs when the pH of the tooth's surface falls below 5.5, resulting in tooth decay. Due to its aciduric, acidogenic, and adhesion capabilities, Gram-positive bacteria phenotype, primarily the mutant versions of streptococci mainly Streptococcus mutans and Streptococcus sobrinus is thought to be the primary causative organism of dental caries [71,72].

The influence of Cranberry's PACs on the formation, persistence, and development of dental biofilm has been studied. Cranberry PACs' capacity to suppress the activity and synthesis of Glucosyl Transferase (GTF) and Fructosyl Transferase (FTF), which are involved in the formation of exopolysaccharides by S. mutans, has been attributed to their ability to prevent sucrose-dependent biofilm development [73]. Furthermore, Cranberry PACs can prevent bacterial coaggregation, diminish bacterial hydrophobicity, and change cell surface molecules to hinder non-sucrosedependent biofilm formation [74]. In a human trial, it is concluded that the daily usage of Cranberry-containing mouthwash for six weeks can reduce counts of the mutant streptococcal versions in saliva [75].

Another study conducted on children; Gupta et al. revealed that the presence of NDM in the mouthwash can significantly reduce the Streptococcal count in the oral environment [72]. Cranberry PACs have also shown a promise role in the prevention and treatment of periodontal diseases involving gingivitis and periodontitis. Cranberry extract has been demonstrated to diminish periodontopathogen-induced inflammation by lowering inflammatory cytokines, including IL-1, IL-6, IL-8, as well as TNF-α in macrophages [65,74].

Antifungal effect: Fungal infections are becoming more common at an alarming rate, posing a significant challenge to the healthcare providers. This rise is directly linked to the growing number of immune compromised people in addition to the changes in medical practice, such as the use of immunosuppressive medicines and intense chemotherapy. The health problems attributed to pathogenic fungi have also been exacerbated by HIV and other disorders that produce immunosuppression. In addition, many fungal phenotypes are becoming more resistant to traditional antifungal drugs like fluconazole and amphotericin B. These two factors deepen the need for finding potent alternatives, primarily from natural sources [76,77].

Cranberry's capacity to suppress the growth of opportunistic human fungal pathogens that cause oral, respiratory, cutaneous, and systemic infections has recently gotten more attention [78]. Isolated Cranberry proanthocyanidin oligomers can suppress the growth of a variety of human pathogenic fungus species. Candida krusei, Candida glabrata, Cryptococcus neoformans, and Candida lusitaniae all showed vulnerability to micromolar quantities of PAC fractions extracted from Cranberry fruit. Higher antifungal activity was seen as PAC oligomers concentration increased, which could be attributed to an increase in the number of free hydroxyl groups available for interaction with proteins involved in organism development and viability [79].

Furthermore, Rane and his colleagues reported a remarkable in-vitro action of Cranberry PACs against the formation of C. albicans biofilm in artificial urine. Where anti-adherence characteristics, iron chelation, or both are thought to be responsible for the Cranberry PAC action against C. albicans biofilm development [78]. In the context of dental caries, Cranberry extract has reported to suppress cariogenic pathogenicity features of S. mutans and C. albicans dual-species biofilms in an in-vitro model [80].

Metabolic syndrome relieving potential

Metabolic syndrome is a complex disorder characterized by a cluster of cardiovascular risk factors, including central obesity, dyslipidemia, hypertension, impaired glucose metabolism, and associated with a hepatic manifestation represented as Non-Alcoholic Fatty Liver Disease (NAFLD). Consequently, increasing the risk of coronary heart diseases and type 2 diabetes mellitus [81].

Consumption of Cranberry and its-based products may have favorable effects on metabolic syndrome, influencing one or more of its components, a multitude of inflammatory biomarkers, and oxidative stress, as revealed by observational and interventional studies in humans [82].

Through a clinical trial, Lee et al. investigated the effect of Cranberry extract on lipid profiles in Type 2 diabetic patients. The patients who received Cranberry extract supplement, one capsule of 500 mg Cranberry powder after each meal for 12 weeks, exhibited lowering in the atherosclerotic cholesterol profiles. Total cholesterol, Low-Density Lipoprotein (LDL) cholesterol, and the total High-Density Lipoprotein (HDL) cholesterol ratio all decreased considerably in the Cranberry supplemented patients as compared to the placebo patients. Also, Cranberry supplements have a neutral effect on glycemic control in Type 2 diabetic subjects taking oral glucose-lowering agents [83].

The increasing prevalence of metabolic syndrome has been linked to a hepatic manifestation known as Non-Alcoholic Fatty Liver Disease (NAFLD). For instance, a veterinary study was conducted to estimate the hepatoprotective effect of Cranberry using a model, in which, the nonalcoholic fatty liver disease was induced in rats administered either or both of high fat cholesterol diet and Cranberry bulk supplement (50 and 100 mg/ kg/day, three times a week orally for eight weeks). Cranberry supplement dramatically decreased oxidative stress, hepatic steatosis, inflammatory state by lowering the expression of IL-6, TNF-α, and NF-kB. This nutraceutical also enhanced insulin sensitivity and markedly increased the expression of adiponectin. Most importantly, this study revealed that Cranberry may increase Nrf-2 expression in hepatic tissues and considerably reduce collagen formation and expression of fibrotic markers (TGF-β and α-SMA) in a NAFLD model, indicating that Cranberry can significantly reduce liver fibrosis development [84].

Parallel results have been found through a randomized clinical trial conducted by Hormoznejad et al., suggesting that 288 mg of Cranberry extract, which is equivalent to 26 g of dried Cranberry, might improve the management of NAFLD. This is attributable in part to the improvement of insulin resistance and the reduction of serum levels of alanine aminotransferase [85].

In a scope similar to the previous studies, many clinical trials found that eight weeks of Cranberry juice consumption may improve the antioxidant status and reduce the cardiovascular disease risk factors. This can be achieved by enhancing gluco-regulation with a positive impact on the insulin resistance homeostasis model. In addition, Cranberry was ably downregulating inflammatory biomarkers, increasing HDL cholesterol, lowering fasting serum triglycerides, decreasing serum C-reactive protein, and lowering diastolic blood pressure. Accordingly, it has been concluded that Cranberry juice consumption can resolve some cardiovascular risk factors in the disorder named metabolic syndrome [86-89].

On the other hand, Cranberry anthocyanins can modulate the plasma lipoprotein profile by lowering total plasma cholesterol, non-HDL cholesterol and non-HDL cholesterol/HDL-cholesterol ratio. The cholesterol-lowering effect of Cranberry anthocyanins is primarily mediated by the increased excretion of total neutral and acidic faecal sterols [90,91].

According to Xie et al., Cranberry anthocyanins can possess an effective pancreatic lipase inhibiting activity, a well-known target of orlistat. In this study, ultrafiltration was offered as an efficient approach for screening pancreatic lipase inhibitors. Four Cranberry anthocyanins involving cyanidin- 3-O-arabinoside, peonidin-3-O-arabinoside, cyanidin-3-O-galactoside and, peonidin-3-O-galactoside were identified as potent pancreatic lipase inhibitors. The results gathered from molecular dynamics, molecular docking, circular dichroism spectroscopy, and fluorescence spectroscopy illustrated that the aforementioned Cranberry anthocyanins could interact with the active site of pancreatic lipase. Hinting that Cranberry supplement can be exploited to prevent the absorption of lipids and facilitate the treatment and prevention of obesity [92].

Antioxidant potential

The lack of equilibrium, between the incidence of Reactive Species (ROS/ RNS) and the organism's ability to counteract their induced damage via the antioxidative defence systems, was characterized as oxidative stress. This overwork is caused by an increase in the ROS/RNS production or a decrease in the antioxidant protection capacity. As a result, endogenous systems' ability to combat oxidative attacks directed at target biomolecules is diminished [93].

Specific factors that cause oxidative damage in cells may be triggered by oxidative stress, such as the formation of mutagenic compounds, overexpression of oncogenes, inflammation, or promotion of atherogenic activity. Consequently, the risk of cardiovascular diseases, neurodegeneration, carcinogenesis, diabetes, liver diseases, and kidney diseases increased [94,95].

Antioxidants are bioactive molecules that can delay or prevent oxidative damage. They are effective when they prevent oxidative damage by blocking free radical-initiated chain reactions and eliminating them. Aside from the endogenous antioxidant enzymes including catalase, glutathione reductase, superoxide dismutase, and glutathione peroxidase, the antioxidant consumption through the diet or supplements is an additional protective element in maintaining cellular redox homeostasis. To quench the damaging free radicals, the endogenous and exogenous antioxidant defense systems can interact and operate synergistically [96].

Cranberries have been shown to exhibit a beneficial effect on oxidative stress-related disorders. Using HepG2 cells, Martín and coworkers investigated the hepatoprotective effect of Cranberry juice and powdered Cranberry extract in the face of oxidative stress. Pre-treatment of HepG2 cells with the powders for twenty hours resulted in a significant reduction of cellular damage induced by tert-butyl hydroperoxide (t-BOOH). Both powders have considerably reduced the over-activated glutathione peroxidase, glutathione reductase, and Malondialdehyde (MDA). Although the juice powder has a lower antioxidant activity than the extract, it can modulate protein signaling pathways at the molecular level to prevent cell damage. Manifesting that, Cranberry chemo-constituents may preserve hepatocytes from oxidative stress by altering GSH levels, antioxidant enzyme activity, MDA plus ROS production, and cell signaling pathways [97].

Another study that looked at the protective effects of Cranberry extract against iron-induced hepatic toxicity in rats found that the extract possesses potent hepatoprotective properties against iron sulfate-induced liver injury. These benefits could be attributed to Cranberry's membrane protective action via antioxidant and free radical scavenging activities [98]. Furthermore, the results of a study carried out by Kim and colleagues indicated that Cranberry powder may supply adequate antioxidants to help hypercholesterolemic rats exposed to lipopolysaccharide regain their antioxidant capacity [99].

These findings imply that Cranberry and its based products can be used to serve as a springboard for the development of newer, safer, and more effective free radical scavenging agents.

Anti-inflammatory potential

Inflammation is the body's defence mechanism against infections, chemicals, and toxins. If inflammation becomes a chronic condition, it may play a crucial role in the evolution of various chronic noncommunicable diseases, including cardiovascular disease, metabolic syndrome, neurodegenerative diseases, and some malignancies [100-103]. The nuclear factor-κB (NF- κB) plays an important part in the signal transduction pathways that are involved in the inflammatory disorders, in addition to other mediators [104].

A recent study carried out by Yu et al. revealed that PAC-rich Cranberry extract can inhibit the lipopolysaccharide-induced inflammatory responses in the macrophages of mouse bone marrow and RAW264.7. In both cell phenotypes, the extract significantly reduced the production of proinflammatory mediators COX-2, iNos, Il-6, TNF-α, and Mcp-1. The suggested potential mechanisms include the inhibition of NF-B p65 phosphorylation and acetylation levels of histone H4 in both cell types, as well as an increase in HDAC3 protein production [105]. In an earlier study, Denise and colleagues concluded similar results. The Caco-2/15 intestinal cells pre-incubated with Cranberry extract were found to have a reduced pro-inflammatory mediator TNF-α and IL-6 in addition to a lowered NF-κB activation rate [106].

Antitumor potential

Despite ongoing breakthroughs in chemotherapy research, cancer continues to be a crucial challenge for modern medicinal chemistry, necessitating increased global efforts to produce more effective anticancer medicines with fewer side effects to battle this disease [107].

Natural products have been demonstrated promising chemotherapeutic properties in the treatment of a variety of cancers. phytochemicals or their derivatives are already used in the management of different types of cancer. Cranberry and its based products are thought to have anticancer potential due to their high phytochemicals content including the anthocyanins, flavonoids, and phenolic acids [108,109].

Khairnar et al. investigated the anticancer activity of Cranberry extract against KB (Nasopharyngeal carcinoma) and AW13516 (low to moderately differentiated squamous cell carcinoma of the tongue). The authors found that the extract exhibited good anti-proliferative properties against the KB cell line with no remarkable activity against AW13516 cell line [110].

In the case of ovarian carcinoma, highly pure PAC isolated from Cranberry extract has been reported to inhibit angiogenesis and ovarian cancer viability in vitro. Chemotherapy-resistant human ovarian adenocarcinoma (SKOV- 3) cells were treated with PAC that arrested the cell cycle and induced apoptosis. PAC-1 also inhibited VEGF (Vascular Endothelial Growth Factor) function in endothelial cells in addition to the suppression of pro-survival Pi3K/AKT signaling in both ovarian cancer and endothelial cells, which was favorably linked with the prevention of endothelial tube formation.

Using DU145 (human prostate adenocarcinoma) cells, some studies reported that apoptosis could be induced in these cells in response to the cranberry extract treatment, MacLean and colleagues found that Cranberryinduced in vitro apoptosis of DU145 cells can be accomplished through increased caspase-8 and -9 activities [111,112]. Likewise, a researcher and his team found that the daily consumption of 1500 mg powdered Cranberry fruit for a mean of one month lowered serum PSA (prostate-specific antigen) in patients with prostate cancer as Cranberry constituents can regulate the expression of androgen-responsive genes [113].

Discussion and Conclusion

Several centuries ago, Vaccinium macrocarpon received significant attention for its advantageous effects on humans. The dietary supplements of cranberry have been developed in recent decades as an alternate and convenient dietary source of its phytochemicals. Various Cranberry products contain numerous phytoconstituents such as proanthocyanidins, anthocyanins, flavonols, organic acids, and phenolic acids. The antioxidant, antimicrobial, anti-inflammatory, and antitumor activities found in different in vitro, in in vivo, and clinical studies seem to be due to this diverse and rich array of cranberry phytochemicals. Reviewed data in this study strongly imply that cranberry supplements consumption can help manage metabolic syndrome components and protect against cardiovascular diseases, malignancies, microbial infections affecting oral health, urinary tract, and Helicobacter pylori-induced ulcers. Overall, this paper concluded that cranberry extract can be exploited as a viable and promising tool to combat a wide range of human diseases.


  1. Lipson, SM, G Karalis, L Karthikeyan and FS Ozen, et al. “Mechanism of Anti-Rotavirus Synergistic Activity by Epigallocatechin Gallate and a Proanthocyanidin-Containing Nutraceutical.” Food Environ Virol 9 (2017): 434-443.

Citation: Khalil Raghad Riyadh, Eman Tareq Mohammed and Yasser Fakri Mustafa. "Various Promising Biological Effects of Cranberry Extract: A Review" Clin Schizophr Relat Psychoses 15S(2021). Doi: 10.3371/ CSRP.KRET.113021.

Copyright: © 2021 Khalil RR, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.